Literature DB >> 21849919

Neurocognitive impairment in adults with moyamoya disease without stroke.

Peter Karzmark1, Penelope D Zeifert, Teresa E Bell-Stephens, Gary K Steinberg, Leslie J Dorfman.   

Abstract

BACKGROUND: Adults with moyamoya disease (MMD) have been shown to manifest cognitive impairment, but it is unclear whether this is the result of ischemic stroke.
OBJECTIVE: To determine whether adults with MMD but without stroke have cognitive impairment.
METHODS: We performed detailed neuropsychological assessments in 30 adults with angiographically confirmed MMD without magnetic resonance imaging (MRI) evidence of stroke.
RESULTS: Twenty patients (67%) exhibited small T2 hyperintensities in the cerebral subcortical white matter on brain MRI but no evidence of gray matter damage. Significant cognitive impairment, defined as half of test scores ≥ 1 SD below the normal mean, was present in 7 patients (23%). Executive functioning, mental efficiency, and word finding were the ability areas most frequently impaired, whereas memory was relatively intact. Clinically significant emotional distress (depression and/or anxiety) was present in 11 patients (37%). Comparable cognitive findings were also observed in the subset of 10 patients (33%) with completely normal static brain MRI.
CONCLUSION: Cognitive impairment in MMD can occur in the absence of ischemic stroke as manifested on MRI.

Entities:  

Mesh:

Year:  2012        PMID: 21849919     DOI: 10.1227/NEU.0b013e3182320d1a

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  21 in total

1.  A "wavering puff of smoke": a rare case of moyamoya disease.

Authors:  Anna Scalise; Maria Elena Laino; Benedetto Petralia; Antonella Piani; Gian Luigi Gigli
Journal:  Neurol Sci       Date:  2017-07-20       Impact factor: 3.307

2.  Erroneous Resting-State fMRI Connectivity Maps Due to Prolonged Arterial Arrival Time and How to Fix Them.

Authors:  Hesamoddin Jahanian; Thomas Christen; Michael E Moseley; Greg Zaharchuk
Journal:  Brain Connect       Date:  2018-08

3.  Influence of Moyamoya disease on psychopathological abnormality in young males in Korea: analysis of multiphasic personal inventory test.

Authors:  Chang Hyun Oh; Hyeonseon Park; Eunyoung Kim; Dong-Keun Hyun; Joonho Chung
Journal:  Neurol Sci       Date:  2012-08-01       Impact factor: 3.307

4.  Functional cortical and cerebellar reorganization in a case of moyamoya disease.

Authors:  Rocco S Calabrò; Placido Bramanti; Annalisa Baglieri; Francesco Corallo; Rosaria De Luca; Simona De Salvo; Silvia Marino
Journal:  Innov Clin Neurosci       Date:  2015 Jan-Feb

5.  Characteristics of Diffusional Kurtosis in Chronic Ischemia of Adult Moyamoya Disease: Comparing Diffusional Kurtosis and Diffusion Tensor Imaging.

Authors:  K Kazumata; K K Tha; H Narita; Y M Ito; H Shichinohe; M Ito; H Uchino; T Abumiya
Journal:  AJNR Am J Neuroradiol       Date:  2016-03-24       Impact factor: 3.825

Review 6.  Recent advances in moyamoya disease: pathophysiology and treatment.

Authors:  Annick Kronenburg; Kees P J Braun; Albert van der Zwan; Catharina J M Klijn
Journal:  Curr Neurol Neurosci Rep       Date:  2014-01       Impact factor: 5.081

7.  Neuropsychological impairment in adults with moyamoya angiopathy: preoperative assessment and correlation to MRI and H215O PET.

Authors:  Constantin Roder; Patrick Haas; Monika Fudali; Monika Milian; Ulrike Ernemann; Philipp T Meyer; Marcos Tatagiba; Nadia Khan
Journal:  Neurosurg Rev       Date:  2019-11-14       Impact factor: 3.042

8.  Changes in Brain Functional Network Connectivity in Adult Moyamoya Diseases.

Authors:  Gaoxing Zheng; Yu Lei; Yuzhu Li; Wei Zhang; Jiabin Su; Xiaoying Qi; Liang Chen; Xin Zhang; Yuxiang Gu; Yuguo Yu; Ying Mao
Journal:  Cogn Neurodyn       Date:  2021-02-07       Impact factor: 3.473

9.  Demographic and clinical characteristics of middle-aged versus younger adults enrolled in a clinical trial of a web-delivered psychosocial treatment for substance use disorders.

Authors:  Raj K Kalapatapu; Aimee Campbell; Efrat Aharonovich; Mei-Chen Hu; Frances R Levin; Edward V Nunes
Journal:  J Addict Med       Date:  2013 Jan-Feb       Impact factor: 3.702

Review 10.  Cognitive Dysfunction Survey of the Japanese Patients with Moyamoya Disease (COSMO-JAPAN Study): study protocol.

Authors:  Yasushi Takagi; Susumu Miyamoto
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-02-20       Impact factor: 1.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.